ArticleEuropean thyroid journal2025
Investigating factors associated with thyroid hormone measurements during pregnancy.
Article in European thyroid journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate assessment of thyroid status is essential for maternal and fetal management during pregnancy. This study measured human chorionic gonadotropin (HCG), albumin, and thyroxine-binding globulin (TBG) levels during pregnancy to clarify how their fluctuations affect thyroid hormone measurements by two immunoassays - chemiluminescent immunoassay (CLIA) and electrochemiluminescence immunoassay (ECLIA). Method: Free thyroxine (FT4), free triiodothyronine (FT3), and thyrotropin (TSH) levels were measured in 897 serum samples obtained from 604 pregnant women by two immunoassays. In 176 cases selected from each trimester, thyroid hormone concentrations were also measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) following ultrafiltration. Associations between thyroid function and relevant determinants were evaluated using multivariable regression analysis. Results: Throughout pregnancy, 64 samples (7.13%) measured by CLIA and 241 samples (26.87%) measured by ECLIA had TSH concentrations less than 0.01 mIU/L. The upper limits of thyroid hormone concentrations were observed between 8 and 15 weeks of gestation. In late pregnancy, the lower limits of thyroid hormone concentrations determined by the immunoassays fell below the lower limits of the nonpregnant reference intervals. Thyroid hormone concentrations measured by immunoassay correlated significantly with LC-MS/MS concentrations. In multivariable regression analysis, only HCG was significantly associated with immunoassay measurements of thyroid hormones. Under conditions of TBG ≥31 μg/mL, women with albumin <3.8 g/dL had lower thyroid hormone concentrations than those with ≥3.8 g/dL. Conclusion: Gestational thyroid hormone concentrations appear to be influenced by HCG levels. As with LC-MS/MS use, immunoassay measurements may vary with albumin and TBG concentrations. These findings underscore the need to consider such fluctuations when interpreting thyroid function tests in pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.